NASDAQ · IART
Healthcare · Medical - Devices
$15.69
Up+$0.37 (+2.36%)
Updated Sep 17, 2026, 12:09 AM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 19 trading sessions · Daily adjusted prices
IART closed at $15.69 after 19 trading sessions, down 8.99% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $15.69 | $16.035 | $15.20 | $15.69 | 1.08M |
| Sep 14, 2026 | $15.36 | $15.80 | $15.36 | $15.71 | 1.14M |
| Sep 11, 2026 | $16.06 | $16.22 | $15.33 | $15.50 | 792.03K |
| Sep 10, 2026 | $15.93 | $16.035 | $15.3878 | $15.54 | 1.36M |
| Sep 9, 2026 | $16.10 | $16.46 | $15.99 | $16.25 | 578.4K |
| Sep 8, 2026 | $16.48 | $16.5498 | $15.985 | $16.26 | 621.8K |
| Sep 4, 2026 | $16.32 | $16.78 | $16.25 | $16.72 | 674.91K |
| Sep 3, 2026 | $17.09 | $17.11 | $16.28 | $16.44 | 998.47K |
| Sep 2, 2026 | $16.80 | $17.205 | $16.655 | $16.81 | 528.86K |
| Sep 1, 2026 | $16.84 | $17.075 | $16.54 | $16.62 | 559.67K |
| Aug 31, 2026 | $16.81 | $16.95 | $16.48 | $16.92 | 581.07K |
| Aug 28, 2026 | $16.97 | $17.33 | $16.87 | $16.89 | 776.24K |
| Aug 27, 2026 | $16.85 | $17.165 | $16.79 | $16.85 | 449.76K |
| Aug 26, 2026 | $16.85 | $17.095 | $16.615 | $16.88 | 489.36K |
| Aug 25, 2026 | $16.73 | $16.865 | $16.39 | $16.79 | 369.54K |
| Aug 24, 2026 | $16.74 | $16.9999 | $16.39 | $16.69 | 654.66K |
| Aug 21, 2026 | $16.81 | $16.935 | $16.44 | $16.74 | 551.8K |
| Aug 20, 2026 | $17.01 | $17.465 | $16.555 | $16.59 | 582.35K |
| Aug 19, 2026 | $17.65 | $18.37 | $17.16 | $17.24 | 652.37K |
The latest Smart Investors Daily articles mentioning IART.
IART research
Company profile and research snapshot.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jul 30, 2026 | Wells Fargo | Equal-Weight | — |
| Jul 28, 2026 | UBS | Neutral | — |
| Jul 16, 2026 | Truist Securities | Hold | — |
| Jul 9, 2026 | BMO Capital | Market Perform | — |
| Jul 8, 2026 | Citigroup | Neutral | — |
No generated briefing is available yet.
SeekingAlpha · Sep 15, 2026
Integra LifeSciences Holdings Corporation (IART) Morgan Stanley 24th Annual Global Healthcare Conference September 15, 2026 4:05 PM EDTCompany...
Yahoo · Sep 10, 2026
Let’s dig into the relative performance of Integra LifeSciences (NASDAQ:IART) and its peers as we unravel the now-completed Q2 surgical equipment & consumables - specialty earnings season.
Yahoo · Sep 10, 2026
What a time it’s been for Integra LifeSciences. In the past six months alone, the company’s stock price has increased by a massive 70.2%, reaching $16.26 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Yahoo · Sep 4, 2026
PRINCETON, N.J., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that Lea Knight, chief financial officer, and Michael McBreen, chief commercial officer, will present at the 2026 Wells Fargo Healthcare Conference on Wednesday, September 9, 2026, at 2:15 p.m. ET. Stuart Essig, chairman and chief executive officer, will present at the 2026 Morgan Stanley Healthcare Conference on Tuesday, Septe
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning IART.
